James J. Schupsky

1.1k total citations
14 papers, 939 citations indexed

About

James J. Schupsky is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, James J. Schupsky has authored 14 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Physiology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in James J. Schupsky's work include Pain Mechanisms and Treatments (8 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). James J. Schupsky is often cited by papers focused on Pain Mechanisms and Treatments (8 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). James J. Schupsky collaborates with scholars based in United States. James J. Schupsky's co-authors include Richard P. Shank, Robert B. Raffa, E E Codd, Jeffry L. Vaught, Bruce E. Maryanoff, Samuel Nortey, Henry I. Jacoby, Joseph F. Gardocki, Robert B. Raffa and Susanna J. Dodgson and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and International Journal of Pharmaceutics.

In The Last Decade

James J. Schupsky

14 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James J. Schupsky United States 10 321 302 280 257 202 14 939
Richard J. Thurlow United Kingdom 8 526 1.6× 514 1.7× 215 0.8× 502 2.0× 136 0.7× 9 1.2k
Mark G. Vartanian United States 19 521 1.6× 516 1.7× 253 0.9× 252 1.0× 170 0.8× 30 1.2k
K. Alexander United States 13 238 0.7× 394 1.3× 153 0.5× 129 0.5× 126 0.6× 25 1.2k
Nirmala Suman‐Chauhan United Kingdom 22 909 2.8× 816 2.7× 344 1.2× 420 1.6× 196 1.0× 39 1.7k
Edward T. Hellriegel United States 19 124 0.4× 191 0.6× 149 0.5× 149 0.6× 125 0.6× 48 1.1k
J. M. A. Sitsen Netherlands 17 271 0.8× 605 2.0× 265 0.9× 227 0.9× 90 0.4× 42 1.4k
Theodore C. Spaulding United States 17 507 1.6× 349 1.2× 94 0.3× 479 1.9× 63 0.3× 41 1.2k
Cara Heers Germany 7 439 1.4× 498 1.6× 427 1.5× 194 0.8× 304 1.5× 13 1.2k
A A Miller United Kingdom 13 549 1.7× 215 0.7× 694 2.5× 83 0.3× 522 2.6× 25 1.1k
Stephen J. Medhurst United Kingdom 13 253 0.8× 236 0.8× 74 0.3× 605 2.4× 40 0.2× 13 1.0k

Countries citing papers authored by James J. Schupsky

Since Specialization
Citations

This map shows the geographic impact of James J. Schupsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James J. Schupsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James J. Schupsky more than expected).

Fields of papers citing papers by James J. Schupsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James J. Schupsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James J. Schupsky. The network helps show where James J. Schupsky may publish in the future.

Co-authorship network of co-authors of James J. Schupsky

This figure shows the co-authorship network connecting the top 25 collaborators of James J. Schupsky. A scholar is included among the top collaborators of James J. Schupsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James J. Schupsky. James J. Schupsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bhamra, R.K., Lois E. Bolcsak, Imran Ahmad, et al.. (2003). Activity, pharmacokinetics and tissue distribution of TLC ELL-12 (liposomal antitumor ether lipid) in rats with transplantable, s.c. methylnitrosourea-induced tumors. Anti-Cancer Drugs. 14(6). 481–486. 5 indexed citations
2.
Maryanoff, Bruce E., Michael J. Costanzo, Samuel Nortey, et al.. (2003). Structure−Activity Studies on Anticonvulsant Sugar Sulfamates Related to Topiramate. Enhanced Potency with Cyclic Sulfate Derivatives.. Journal of Medicinal Chemistry. 46(4). 652–652. 2 indexed citations
3.
Perkins, Walter R., Imran Ahmad, Xingong Li, et al.. (2000). Novel therapeutic nano-particles (lipocores): trapping poorly water soluble compounds. International Journal of Pharmaceutics. 200(1). 27–39. 57 indexed citations
4.
Maryanoff, Bruce E., Michael J. Costanzo, Samuel Nortey, et al.. (1998). Structure−Activity Studies on Anticonvulsant Sugar Sulfamates Related to Topiramate. Enhanced Potency with Cyclic Sulfate Derivatives. Journal of Medicinal Chemistry. 41(8). 1315–1343. 94 indexed citations
5.
Raffa, Robert B., James J. Schupsky, & Henry I. Jacoby. (1996). Endothelin-induced nociception in mice: mediation by ETA and ETB receptors.. Journal of Pharmacology and Experimental Therapeutics. 276(2). 647–651. 54 indexed citations
6.
Raffa, Robert B., Cynthia A. Maryanoff, E E Codd, et al.. (1996). Unexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochloride.. Journal of Pharmacology and Experimental Therapeutics. 278(3). 1098–1104. 12 indexed citations
7.
Raffa, Robert B., James J. Schupsky, Dong Ki Lee, & Henry I. Jacoby. (1996). Characterization of endothelin-induced nociception in mice: evidence for a mechanistically distinct analgesic model.. Journal of Pharmacology and Experimental Therapeutics. 278(1). 1–7. 39 indexed citations
8.
Codd, E E, Richard P. Shank, James J. Schupsky, & Robert B. Raffa. (1995). Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception.. Journal of Pharmacology and Experimental Therapeutics. 274(3). 1263–1270. 306 indexed citations
9.
Shank, Richard P., Joseph F. Gardocki, Jeffry L. Vaught, et al.. (1994). Topiramate: Preclinical Evaluation of a Structurally Novel Anticonvulsant. Epilepsia. 35(2). 450–460. 302 indexed citations
10.
Raffa, Robert B. & James J. Schupsky. (1994). Opioid μ receptor subtypes (possibly μ1 and μ2) revealed by morphine-induced antinociception vs endothelin-1 in recombinant inbred CXBK mice. Life Sciences. 54(4). PL57–PL62. 5 indexed citations
11.
Martinez, Rebecca P., et al.. (1994). Etonitazene-induced antinociception in μ1 opioid receptor deficient CXBK mice: Evidence for a role for μ2 receptors in supraspinal antinociception. Life Sciences. 54(21). PL369–PL374. 11 indexed citations
12.
Maryanoff, Bruce E., et al.. (1993). Anticonvulsant sugar sulfamates. Potent cyclic sulfate and cyclic sulfite analogues of topiramate. Bioorganic & Medicinal Chemistry Letters. 3(12). 2653–2656. 8 indexed citations
13.
Raffa, Robert B., James J. Schupsky, Rebecca P. Martinez, & Henry I. Jacoby. (1991). Endothelin-1-induced nociception. Life Sciences. 49(11). PL61–PL65. 31 indexed citations
14.
Dubinsky, Barry & James J. Schupsky. (1984). Mechanism of action of suprofen, a new peripheral analgesic, as demonstrated by its effects on several nociceptive mediators. Prostaglandins. 28(2). 241–252. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026